解开Helicobacter pylori:对病变发生,免疫逃避和朝着有效疫苗接种的进展的洞察
Ayman Elbehiry1, Eman Marzouk1, Adil Abalkhail1
1Department of Public Health, College of Applied Medical Sciences, Qassim University, P.O. Box 6666, Buraydah 51452, Saudi Arabia.
杆菌 (H. pylori) 感染在全球范围内造成重大健康问题. 了解它的发病和免疫逃避是开发有效的H.pylori疫苗的关键.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 杆菌 (H. pylori) 是一种广泛的细菌感染,与胃炎,和胃癌有关.
- 诸如cagA,vacA和尿酶之类的毒性因素使H. pylori的殖民化,免疫逃避和慢性炎症成为可能.
- 杆菌对宿主免疫反应的操纵阻碍了自然清除,并使疫苗开发复杂化.
研究的目的:
- 审查 H. pylori 病原和宿主免疫相互作用.
- 探索这些见解如何为有效的H. pylori疫苗设计提供信息.
- 为了满足全球卫生需求,支持开发H. pylori疫苗.
主要方法:
- 文献综述综合了关于H. pylori病变的当前研究.
- 在分子和细胞层面分析宿主-病原体相互作用.
- 整合基础科学发现与翻译性疫苗开发策略.
主要成果:
- 详细阐明H. pylori毒性因子及其在感染中的作用.
- 了解H. pylori的免疫逃避机制.
- 确定H. pylori疫苗设计的关键考虑因素,包括抗原选择,辅助剂选择和输送方法.
结论:
- 对H. pylori病原和免疫反应的洞察对于疫苗开发至关重要.
- 有效的疫苗策略必须解决细菌的免疫调节能力.
- 开发H. pylori疫苗对于全球健康至关重要,尤其是在高负担地区.
更多相关视频
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
03:47Retinal and Choroidal Thickness Changes in Populations with Helicobacter pylori Infection by Swept-Source Optical Coherence Tomography
Published on: November 1, 2024
相关概念视频
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Microorganisms in Medicine and Therapeutics
